LIVE ONLINE Conference Programme

default

Loading

Mistletoe Therapy

06 Nov 2021
Mistletoe Therapy

(Timings are in Greenwich Mean Time - add session to your diary using link below)

Reflections on the first UK mistletoe clinical trial: a feasibility, placebo -controlled randomised trial

Introduction:  A Cochrane review of mistletoe therapy concludes that there is some evidence that mistletoe extracts may benefit quality of life during chemotherapy for breast cancer, but results need replication. The aim of the study was to test the feasibility of a placebo-controlled, double-blind randomised controlled trial of mistletoe therapy in patients with breast cancer.

Co-Authors:

Prof Gene Feder - Professor of Primary Health - University of Bristol
Mrs Susan Bryant - Senior Research Associate - University of Bristol

 

Speakers
Dr Alyson Huntley, Senior Research Fellow, University of Bristol - UK
Dr Lorna Duncan, Senior Research Associate, University of Bristol - UK

The joint congress for ESIM and ISCMR:

Organised in association with:

Gold Sponsors:


 

Silver Sponsors:


 

Supported by: